瑞典研究表明,FIT筛查会降低60岁老年人的高级结肠癌发病率。 Swedish study shows FIT screening lowers advanced colon cancer in 60-year-olds.

瑞典对278 000多名60岁老人进行的一项大型研究发现,直肠癌筛查,特别是低血阈值的胎儿免疫化学测试,大大减少了癌症高发病例。 A large Swedish study of over 278,000 60-year-olds found that colorectal cancer screening, particularly fecal immunochemical tests (FIT) with a low blood threshold, significantly reduces advanced cancer cases. FIT组的癌症率(0.61%)低于控制组的癌症率(0.73%),这很可能是由于消除了先发性聚虫。 The FIT group had a lower cancer rate (0.61%) than the control group (0.73%), likely due to removal of precancerous polyps. 虽然轻微并发症略有增加,特别是在结肠镜检查后,但总体死亡率仍然相似。 While minor complications increased slightly, especially after colonoscopy, overall mortality remained similar. 作为SCREESCO项目的一部分,这项研究持续到2030年,以评估长期生存福利。 The study, part of the SCREESCO project, continues through 2030 to assess long-term survival benefits. 瑞典为60-74岁成年人制定的国家方案已经采用了FIT筛查。 FIT screening is already used in Sweden’s national program for adults aged 60–74.